Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.6/6292 |
Resumo: | Prostate cancer (PCa) is the most common type of cancer in men over the age of 50 in Western countries. The current therapies available are, in many cases, limited and ineffective. Therefore, it is necessary to develop alternative therapies, that can fight specifically and effectively cancer cells. The Six Transmembrane Epithelial Antigen of Prostate 1 (STEAP1) is a protein with six transmembrane domains located in the cell-cell junctions of the secretory epithelium of the prostate. Some studies have reported it as overexpressed in PCa but in normal tissues, its expression is minimal. The structure and cell location of STEAP1 suggest that it may function as a channel for ions. Moreover, it was demonstrated that STEAP1 overexpression induces proliferation of cancer cells. The differential expression of STEAP1 in tissues, associated with its localization, suggests its potential use as a target for cancer therapy. In order to delineate novel strategies for targeting STEAP1 protein, it is necessary to obtain high levels of purified protein. Therefore, the aim of this study is to produce STEAP1 protein in Pichia pastoris X33 Mut+. The use of a eukaryotic system will allow the correct folding of the protein since Pichia pastoris is able to perform post-translation modifications. Our results showed that the target protein is being produced by Pichia pastoris strain and it was identified in the pellet fraction centrifuged at 16000g. Western blot analysis revealed the protein in the correct molecular weight (~ 40 kDa) The best conditions for protein production is a 6 hours fermentation process in BMMH medium with 1.25% methanol and 6% DMSO at 30ºC, 250rpm. The solubilization process should be done using SDS in a concentration of 1-3%. |
id |
RCAP_b80ed785e5d8b59eddbddb797c32791c |
---|---|
oai_identifier_str |
oai:ubibliorum.ubi.pt:10400.6/6292 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+BiossínteseCancro da PróstataPichia Pastoris.Steap1Domínio/Área Científica::Engenharia e Tecnologia::Engenharia QuímicaProstate cancer (PCa) is the most common type of cancer in men over the age of 50 in Western countries. The current therapies available are, in many cases, limited and ineffective. Therefore, it is necessary to develop alternative therapies, that can fight specifically and effectively cancer cells. The Six Transmembrane Epithelial Antigen of Prostate 1 (STEAP1) is a protein with six transmembrane domains located in the cell-cell junctions of the secretory epithelium of the prostate. Some studies have reported it as overexpressed in PCa but in normal tissues, its expression is minimal. The structure and cell location of STEAP1 suggest that it may function as a channel for ions. Moreover, it was demonstrated that STEAP1 overexpression induces proliferation of cancer cells. The differential expression of STEAP1 in tissues, associated with its localization, suggests its potential use as a target for cancer therapy. In order to delineate novel strategies for targeting STEAP1 protein, it is necessary to obtain high levels of purified protein. Therefore, the aim of this study is to produce STEAP1 protein in Pichia pastoris X33 Mut+. The use of a eukaryotic system will allow the correct folding of the protein since Pichia pastoris is able to perform post-translation modifications. Our results showed that the target protein is being produced by Pichia pastoris strain and it was identified in the pellet fraction centrifuged at 16000g. Western blot analysis revealed the protein in the correct molecular weight (~ 40 kDa) The best conditions for protein production is a 6 hours fermentation process in BMMH medium with 1.25% methanol and 6% DMSO at 30ºC, 250rpm. The solubilization process should be done using SDS in a concentration of 1-3%.O cancro da próstata é o tipo de cancro mais comum entre os homens com mais de 50 anos nos países ocidentais. As terapias atuais disponíveis são, em alguns casos, limitadas e ineficazes. Por isso, é necessário desenvolver terapias alternativas que possam combater de forma mais específica e eficaz as células tumorais. A proteína Six Transmembrane Epithelial Antigen of the Prostate 1 (STEAP1) é formada por seis domínios transmembranares, localizada nas junções célula-célula do epitélio prostático. Diversos estudos indicam que a STEAP1 se encontra sobre-expressa no cancro da próstata mas em tecidos normais, a sua expressão é mínima. A sua localização e estrutura celular sugere que esta proteína pode funcionar como um canal iónico. Logo, a expressão diferencial da STEAP1 entre tecidos, associada com a sua localização, sugerem o seu uso como possível alvo terapêutico do cancro. Para delinear novas formas de terapia usando como alvo a STEAP1, é necessário obter-se elevados níveis de proteína purificada. Portanto, o objetivo deste estudo é produzir a proteína STEAP1 em Pichia pastoris X33. A utilização de um sistema eucariótico irá permitir o enovelamento correto da proteína, visto a Pichia pastoris ser capaz de realizar reações pós-tradução. Os nossos resultados demonstraram que a proteína alvo é eficazmente produzida em Pichia pastoris e foi identificada na fração centrifugada a 16000g. Análise por Western blot revela a proteína com o peso molecular correto (~40 kDa). As melhores condições para a produção da proteína são um processo de fermentação de 6 horas em meio BMMH com 1,25% de metanol e 6% de DMSO a 30ºC, 250 rpm. O passo de solubilização deve ser efetuado utilizando SDS numa concentração de 1-3%.Batista, Cláudio Jorge MaiaPassarinha, Luís António PaulinouBibliorumSantos, Margarida Maria Antunes dos2018-11-05T14:43:20Z2016-11-112016-10-102016-11-11T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.6/6292TID:201771241enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-12-15T09:44:42Zoai:ubibliorum.ubi.pt:10400.6/6292Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:47:03.014962Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ |
title |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ |
spellingShingle |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ Santos, Margarida Maria Antunes dos Biossíntese Cancro da Próstata Pichia Pastoris. Steap1 Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
title_short |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ |
title_full |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ |
title_fullStr |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ |
title_full_unstemmed |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ |
title_sort |
Biosynthesis optimization of STEAP1 protein in Pichia pastoris X33 MUT+ |
author |
Santos, Margarida Maria Antunes dos |
author_facet |
Santos, Margarida Maria Antunes dos |
author_role |
author |
dc.contributor.none.fl_str_mv |
Batista, Cláudio Jorge Maia Passarinha, Luís António Paulino uBibliorum |
dc.contributor.author.fl_str_mv |
Santos, Margarida Maria Antunes dos |
dc.subject.por.fl_str_mv |
Biossíntese Cancro da Próstata Pichia Pastoris. Steap1 Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
topic |
Biossíntese Cancro da Próstata Pichia Pastoris. Steap1 Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
description |
Prostate cancer (PCa) is the most common type of cancer in men over the age of 50 in Western countries. The current therapies available are, in many cases, limited and ineffective. Therefore, it is necessary to develop alternative therapies, that can fight specifically and effectively cancer cells. The Six Transmembrane Epithelial Antigen of Prostate 1 (STEAP1) is a protein with six transmembrane domains located in the cell-cell junctions of the secretory epithelium of the prostate. Some studies have reported it as overexpressed in PCa but in normal tissues, its expression is minimal. The structure and cell location of STEAP1 suggest that it may function as a channel for ions. Moreover, it was demonstrated that STEAP1 overexpression induces proliferation of cancer cells. The differential expression of STEAP1 in tissues, associated with its localization, suggests its potential use as a target for cancer therapy. In order to delineate novel strategies for targeting STEAP1 protein, it is necessary to obtain high levels of purified protein. Therefore, the aim of this study is to produce STEAP1 protein in Pichia pastoris X33 Mut+. The use of a eukaryotic system will allow the correct folding of the protein since Pichia pastoris is able to perform post-translation modifications. Our results showed that the target protein is being produced by Pichia pastoris strain and it was identified in the pellet fraction centrifuged at 16000g. Western blot analysis revealed the protein in the correct molecular weight (~ 40 kDa) The best conditions for protein production is a 6 hours fermentation process in BMMH medium with 1.25% methanol and 6% DMSO at 30ºC, 250rpm. The solubilization process should be done using SDS in a concentration of 1-3%. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-11-11 2016-10-10 2016-11-11T00:00:00Z 2018-11-05T14:43:20Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.6/6292 TID:201771241 |
url |
http://hdl.handle.net/10400.6/6292 |
identifier_str_mv |
TID:201771241 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799136366155530240 |